2.17 (-%)
As of Nov 22, 2024
Source:
Senti Biosciences, Inc. is a preclinical biotechnology company developing next-generation cell and gene therapies engineered with our gene circuit platform technologies to fight challenging diseases. Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | (650) 382-3281 |
Industry | |
CEO | Timothy Lu |
Website | www.sentibio.com |